Sirolimus Adverse Event Profile in a Non-Clinical Trial Cohort of Heart Transplantation Patients

BACKGROUND: Sirolimus has been used increasingly in heart transplantation for its ability to reduce acute rejection, prevent the progression of cardiac allograft vasculopathy (CAV), and preserve renal function. We sought to assess the adverse reactions associated with the use of sirolimus compared t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sallam, Karim, Bhumireddy, Geetha P., Evuri, Vishnu D., Abella, Joshua P., Haddad, Francois, Valantine, Hannah A., Nguyen, Patricia K., Pham, Michael X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824988/
https://www.ncbi.nlm.nih.gov/pubmed/33462174
http://dx.doi.org/10.12659/AOT.923536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824988/
https://www.ncbi.nlm.nih.gov/pubmed/33462174
http://dx.doi.org/10.12659/AOT.923536

Ejemplares similares